Prognostic value of transcriptional expression of fibronectin type III domain-containing 4 (FNDC4) in head and neck carcinoma patients treated with chemoradiotherapy
Camacho, M., León, X., Pujol, A., Montezuma, L., Quer, M., & García, J. (2022). Prognostic value of transcriptional expression of … Read More
